Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL670226 | 0.73 | DNMT1 (0.33) | — | |
| SCHEMBL27748204 | 0.73 | MGLL (0.33) | GSK3AGSK3BMGLL | |
| SCHEMBL8169087 | 0.72 | MGLL (0.35) | GSK3AGSK3BMGLL | |
| SCHEMBL1955692 | 0.71 | GSK3A (0.31) | GSK3AGSK3BMGLL | |
| SCHEMBL9414032 | 0.71 | GSK3A (0.31) | GSK3AGSK3BMGLL | |
| SCHEMBL3813596 | 0.71 | MGLL (0.32) | GSK3AGSK3BMGLL | |
| SCHEMBL8163728 | 0.71 | ALDH1A1 (0.32) | — | |
| Hydrochloric Acid SCHEMBL10491222 | 0.71 | GSK3A (0.31) | GSK3AGSK3BMGLL | |
| SCHEMBL8989652 | 0.71 | GSK3A (0.31) | GSK3AGSK3BMGLL | |
| SCHEMBL3677591 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107735422-B | Aqueous peptide-functionalized polyurethane dispersions | 汉高股份有限及两合公司 | 2020-08-07 | — | — | CN | claimed |
| US-7399816-B2 | Maleimidyl-containing material and production method thereof | FUJI XEROX CO., LTD. (JP) | 2008-07-15 | — | — | US | claimed |
| WO-2007044169-A1 | PROCESSES FOR THE PRODUCTION OF HYDROXYALKYLMALEIMIDES | ALBEMARLE CORPORATION (US) | 2007-04-19 | — | — | WO | claimed |
| US-20060128943-A1 | Maleimidyl-containing material and production method thereof | FUJI XEROX CO., LTD. | 2006-06-15 | — | — | US | claimed |
| US-6589510-B2 | For hair-do or hairstyle | WELLA AG (DE) | 2003-07-08 | — | — | US | claimed |
| US-20020090346-A1 | For hair-do or hairstyle | Wella GmbH (DE) | 2002-07-11 | — | — | US | claimed |
| JP-3012414-A | — | — | None | — | — | JP | disclosed |
| US-11999865-B2 | UV curable composition for use in 3D printing | BASF SE (DE) | 2024-06-04 | — | — | US | disclosed |
| EP-3856856-B1 | UV CURABLE COMPOSITION FOR USE IN 3D PRINTING | BASF SE (DE) | 2024-05-29 | — | — | EP | disclosed |
| US-11897995-B2 | Allophanate based dispersing agent | BASF SE (DE) | 2024-02-13 | — | — | US | disclosed |
| US-11878067-B2 | Gel compositions containing copolymer of vinylpyrrolidone and acrylic acid | L'OREAL (FR) | 2024-01-23 | — | — | US | disclosed |
| EP-4041830-B1 | THERMALLY CURABLE TWO-COMPONENT COATING COMPOUNDS | BASF SE (DE) | 2023-12-06 | — | — | EP | disclosed |
| US-11826963-B2 | Active energy ray-curable resin composition and ink for three-dimensional molding support materials | KJ CHEMICALS CORPORATION (JP) | 2023-11-28 | — | — | US | disclosed |
| CN-1291201-A | Water compatible energy curable compositions containing maleimide derivatives | SUN CHEMICAL CORP (US) | 2001-04-11 | — | — | CN | disclosed |
| EP-0878482-A1 | An active energy ray curable composition comprised of a maleimide derivative and a method for curing the said curable composition | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1998-11-18 | — | — | EP | disclosed |
| EP-0257586-B1 | HYDROXYALKYL- AND AMINOALKYL-FUNCTIONALIZED POLYPHENYLENE ETHERS | GENERAL ELECTRIC COMPANY (US) | 1992-01-15 | — | — | EP | disclosed |
| JP-H0312414-A | CURABLE UNSATURATED IMIDE URETHANE COMPOSITION, ITS PRODUCTION AND CURED MOLDED ARTICLE | TEIJIN LTD | 1991-01-21 | — | — | JP | disclosed |
| US-4746708-A | COMPATIBILIZATION OF BLENDS WITH POLYESTERS | GENERAL ELECTRIC COMPANY (US) | 1988-05-24 | — | — | US | disclosed |
| EP-0257586-A2 | Hydroxyalkyl- and aminoalkyl-functionalized polyphenylene ethers | GENERAL ELECTRIC COMPANY (US) | 1988-03-02 | — | — | EP | disclosed |
| WO-1987007280-A1 | HYDROXYALKYL- AND AMINOALKYL-FUNCTIONALIZED POLYPHENYLENE ETHERS | GENERAL ELECTRIC COMPANY (US) | 1987-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060128943-A1 | Maleimidyl-containing material and production method thereof | MEN1, VIP, PTMS | GSK3A 4444/4885GSK3B 4383/4885MGLL 4158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.